Mesenchymal stem cells and immunomodulation: current status and future prospects

The unique immunomodulatory properties of mesenchymal stem cells (MSCs) make them an invaluable cell type for the repair of tissue/ organ damage caused by chronic inflammation or autoimmune disorders. Although they hold great promise in the treatment of immune disorders such as graft versus host dis...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease Vol. 7; no. 1; p. e2062
Main Authors: Gao, F, Chiu, S M, Motan, D A L, Zhang, Z, Chen, L, Ji, H-L, Tse, H-F, Fu, Q-L, Lian, Q
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01-01-2016
Springer Nature B.V
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The unique immunomodulatory properties of mesenchymal stem cells (MSCs) make them an invaluable cell type for the repair of tissue/ organ damage caused by chronic inflammation or autoimmune disorders. Although they hold great promise in the treatment of immune disorders such as graft versus host disease (GvHD) and allergic disorders, there remain many challenges to overcome before their widespread clinical application. An understanding of the biological properties of MSCs will clarify the mechanisms of MSC-based transplantation for immunomodulation. In this review, we summarize the preclinical and clinical studies of MSCs from different adult tissues, discuss the current hurdles to their use and propose the future development of pluripotent stem cell-derived MSCs as an approach to immunomodulation therapy.
Bibliography:These authors contributed equally to this work.
ISSN:2041-4889
2041-4889
DOI:10.1038/cddis.2015.327